# iQIYI, Inc.: Form 20-F for the period ended Dec 31, 2023

- Company: [iQIYI, Inc.](/companies/iq.md) (CIK 1722608)
- Form: 20-F
- Filed: 2024-03-14
- Accepted by EDGAR: Mar 14, 2024, 06:27 ET
- Period: 2023-12-31
- Accession: 0000950170-24-031129
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1722608/000095017024031129/iq-20231231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1722608/000095017024031129/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2023-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2023-01-01 to 2023-12-31 | $4.49bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months, 2023-01-01 to 2023-12-31 | $3.25bn | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 12 months, 2023-01-01 to 2023-12-31 | $248.8m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months, 2023-01-01 to 2023-12-31 | $565.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2023-01-01 to 2023-12-31 | $421.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2023-01-01 to 2023-12-31 | $159.2m | us-gaap:InterestExpense |
| Income tax | 12 months, 2023-01-01 to 2023-12-31 | $11.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2023-01-01 to 2023-12-31 | $271.2m | us-gaap:NetIncomeLoss |
| Operating cash flow | 12 months, 2023-01-01 to 2023-12-31 | $472.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2023-01-01 to 2023-12-31 | $5.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2023-12-31 | $624.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2023-12-31 | $1.78bn | us-gaap:AssetsCurrent |
| Total assets | at 2023-12-31 | $6.28bn | us-gaap:Assets |
| Current liabilities | at 2023-12-31 | $3.15bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2023-12-31 | $4.56bn | us-gaap:Liabilities |
| Short-term borrowings | at 2023-12-31 | $503.1m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2023-12-31 | $1.72bn | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1722608/000095017024031129/iq-20231231.htm

Filed Mar 14, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-031129. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.